tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ASND Stock Latest News

Ascendis Pharma Grants Warrants to Employees
Company AnnouncementsAscendis Pharma Grants Warrants to Employees
3d ago
6K
ASND
BioMarin initiates legal action against Ascendis over patent infringement
PremiumThe Fly
BioMarin initiates legal action against Ascendis over patent infringement
5d ago
ASND
BMRN
Ascendis Pharma Aims for Blockbuster Growth in Endocrinology
PremiumCompany Announcements
Ascendis Pharma Aims for Blockbuster Growth in Endocrinology
5d ago
6K
ASND
Ascendis Pharma Outlines 2025 Strategic Plans and Achievements
PremiumCompany Announcements
Ascendis Pharma Outlines 2025 Strategic Plans and Achievements
5d ago
6K
ASND
Ascendis Pharma initiated with a Buy at UBS
PremiumThe Fly
Ascendis Pharma initiated with a Buy at UBS
11d ago
ASND
Ascendis Pharma Updates Articles for Financial Flexibility
PremiumCompany AnnouncementsAscendis Pharma Updates Articles for Financial Flexibility
19d ago
6K
ASND
Ascendis Pharma price target raised to $220 from $205 at Evercore ISI
Premium
The Fly
Ascendis Pharma price target raised to $220 from $205 at Evercore ISI
29d ago
ASND
Ascendis Pharma announces commercial availability of YORVIPATH in U.S.
Premium
The Fly
Ascendis Pharma announces commercial availability of YORVIPATH in U.S.
1M ago
ASND
Ascendis Pharma Finalizes Key Collaboration with Novo Nordisk
PremiumCompany Announcements
Ascendis Pharma Finalizes Key Collaboration with Novo Nordisk
1M ago
6K
ASND
Ascendis Pharma announces results from New InsiGHTS tril of TransCon hGH
PremiumThe Fly
Ascendis Pharma announces results from New InsiGHTS tril of TransCon hGH
1M ago
ASND
Closing Bell Movers: RH soars 20% on earnings, guidance raise
PremiumThe Fly
Closing Bell Movers: RH soars 20% on earnings, guidance raise
1M ago
NX
RH
Ascendis Pharma’s TransCon hGH Receives FDA Review for Adult Use
PremiumCompany Announcements
Ascendis Pharma’s TransCon hGH Receives FDA Review for Adult Use
1M ago
6K
ASND
Ascendis Pharma announces FDA to review TransCon hGH sBLA
PremiumThe FlyAscendis Pharma announces FDA to review TransCon hGH sBLA
1M ago
ASND
Ascendis Pharma Reviews Share Structure and Capital Strategy
Premium
Company Announcements
Ascendis Pharma Reviews Share Structure and Capital Strategy
1M ago
6K
ASND
Ascendis Pharma price target raised to $207 from $200 at Stifel
Premium
The Fly
Ascendis Pharma price target raised to $207 from $200 at Stifel
2M ago
ASND
Ascendis Pharma price target lowered to $153 from $160 at TD Cowen
PremiumThe Fly
Ascendis Pharma price target lowered to $153 from $160 at TD Cowen
2M ago
ASND
Ascendis Pharma Reports Strong Q3 2024 Results
PremiumCompany Announcements
Ascendis Pharma Reports Strong Q3 2024 Results
2M ago
ASND
Closing Bell Movers: Applied Materials down 6% after earnings, guidance
PremiumThe Fly
Closing Bell Movers: Applied Materials down 6% after earnings, guidance
2M ago
DPZ
INO
Ascendis Pharma Reports Revenue Growth Despite Loss
PremiumCompany Announcements
Ascendis Pharma Reports Revenue Growth Despite Loss
2M ago
6K
ASND
Ascendis Pharma’s Q3 Growth and Strategic Moves
PremiumCompany AnnouncementsAscendis Pharma’s Q3 Growth and Strategic Moves
2M ago
6K
ASND
Ascendis Pharma reports Q3 EPS (EUR 1.72) vs. (EUR 2.88) last year
Premium
The Fly
Ascendis Pharma reports Q3 EPS (EUR 1.72) vs. (EUR 2.88) last year
2M ago
ASND
Ascendis Pharma Expands Capital to Fuel Growth
Premium
Company Announcements
Ascendis Pharma Expands Capital to Fuel Growth
2M ago
6K
ASND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >